Answers are grounded in this paper and cite their sources.
Injectable soft tissue fillers are expected to combine effective volumization, favorable handling, and sustained biostimulation, yet these properties remain difficult to achieve simultaneously. Hyaluronic acid (HA) hydrogels offer good injectability but limited capacity for sustained biostimulation, whereas particulate biostimulators promote tissue remodeling but can impair handling. We developed an injectable composite by incorporating 58S bioactive glass (58S BG) microspheres into cross-linked HA (58S + HA), and compared it with pure HA and calcium hydroxyapatite (CaHA) microsphere-loaded HA (CaHA + HA) across physicochemical, rheological, biological, and in vivo endpoints. 58S + HA exhibited enhanced viscoelasticity (G′ = 205 vs. 55.4 Pa; tanδ = 0.317 vs. 0.895) with substantially lower extrusion force than CaHA + HA (4.6 vs. 11.0 N), and provided sustained Si and Ca release over 90 days. In vitro , 58S + HA maintained cytocompatibility, upregulated COL1A1, COL3A1, and FN1, and did not increase TNF-α or IL-6. In 180-day rabbit subcutaneous implantation, 58S + HA showed comparatively more prominent fibrous stroma and tissue ingrowth without abnormal inflammatory infiltration or tissue damage. These findings show that 58S BG incorporation can extend the biostimulatory function of HA-based fillers while preserving favorable handling, supporting a clinically oriented strategy for multifunctional soft tissue filler development.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: